Wolfgang Koenig, MD; Mark B. Pepys, MD, PhD
Disclosures: Dr. Koenig has received fees for speaking about CRP from Dade–Behring and Instrumentation Laboratory and has been reimbursed for lectures on inflammation and cardiovascular disease by Bristol–Myers Squibb, Merck Sharp and Dohme, and Sankyo. Dr. Pepys has received fees for speaking and consulting about CRP from Abbott Laboratories, Dade–Behring, and Roche Diagnostics.
Requests for Single Reprints: Wolfgang Koenig, MD, Department of Internal Medicine II—Cardiology, University of Ulm Medical Center, Robert-Koch Strasse 8, D–89081 Ulm, Germany; e-mail, email@example.com.
Current Author Addresses: Dr. Koenig: Department of Internal Medicine II—Cardiology, University of Ulm Medical Center, Robert-Koch Strasse 8, D–89081 Ulm, Germany.
Dr. Pepys: Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom.
Koenig W, Pepys MB. C-Reactive Protein Risk Prediction: Low Specificity, High Sensitivity. Ann Intern Med. 2002;136:550–552. doi: 10.7326/0003-4819-136-7-200204020-00014
Download citation file:
Published: Ann Intern Med. 2002;136(7):550-552.
Cardiology, Coronary Risk Factors, Hematology/Oncology, Prevention/Screening.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use